Benchmark, a global aquaculture genetics, health and specialist nutrition firm, managed to half its losses in the third quarter of 2020 as it neared completion of its divestment program.
The group’s overall adjusted loss amounted to £1.5 million (€1.7 million/$2 million) compared with a loss of £3 million (€3.3 million/$4 million) in the same period a year ago.
Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) from continuing operations was £0.3
